Skip to content

Assessment of flaxseed oil and sunflower oil consumption effect on serum lipids, glucose, peroxidation lipid factor and blood pressure in metabolic syndrome patients

Comparison of flaxseed oil and sunflower oil consumption effect on serum triglyceride, HDL-cholesterol, LDL-cholesterol, glucose, MDA and blood pressure in metabolic syndrome patients.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015012020737N1
Enrollment
60
Registered
2015-05-23
Start date
2015-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome. Metabolic disorder, unspecified

Interventions

Intervention 1: 25 cc cold press flaxseed oil daily add to salad or cold food for 7 week. Intervention 2: 25 cc sunflower oil daily add to salad or cold food for 7 week.
Treatment - Other
25 cc cold press flaxseed oil daily add to salad or cold food for 7 week
25 cc sunflower oil daily add to salad or cold food for 7 week

Sponsors

Vice Chancellor for research of Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: waist circumference men = 102cm or 40in and women = 88cm or 35in; fasting blood glucose = 110 mg per dl; HDL cholesterol for men < 40 mg per dl and for women < 50 mg per dl; triglycerides = 150 mg per dl; blood pressure = 130 and 85 mm Hg Exclusion criteria: hypothyroidism; alcoholism; smoking; auto immune disease; chronic pancreatitis; liver dysfunction; kidney disorder or nephritic syndrome; simultaneous subscription in other interventional study; any inflammatory disease or incidence of infection at start or during the study period; consumption of other drug such as aspirin or any NSAID; propranolol; any form of steroids and any kind of lipid lowering agent; angioplasty or heart attack positive history; pregnancy and lactating

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood Pressure (systolic and diastolic). Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Beurer upper arm digital blood pressure monitor.;Fasting Blood Glucose. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Laboratory kit, Pars Azmoon.;Triglyceride. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Laboratory kit, Pars Azmoon.;HDL-cholesterol. Timepoint: Begining of study first day and at the end of study 49th. Method of measurement: Laboratory kit, Pars Azmoon.;Waist circumference. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: By measure tape least circumference between last rib and iliac crest.;LDL-cholesterol. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Laboratory kit, Pars Azmoon.;MDA. Timepoint: Begining of study first day and at the end of study 49th day. Method of measurement: Reaction serum MDA with tiobarbituric acid, measure absorption with florimetry and comparison with standard curve.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefe Akrami

School of Nutrition, Shiraz University of Medical Sciences

akramiat@sums.ac.ir; atefe.akrami@yahoo.com+98 71 3725 7288

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 19, 2026